Houston’s approved charter change focuses on police priorities, diversion and public accounting. It does not create a legal cannabis market or guarantee that possession cannot lead...
Election-night cannabis victories in Massachusetts and Idaho have different practical effects: one protects an existing market, while the other preserves a route to future reform.
A Shibuya screening puts cannabis comedy in conversation with hemp culture, film and public discussion, with a separate online audience award extending into 2027.
Organigram and Aurora have agreed to a Canadian cannabis combination. The proposed deal’s value, competing bid and approval process explain what changes now—and what still has...
A Maryland proposal would let dispensaries show and offer the aroma of cannabis under security conditions. Its timing and accompanying retail changes deserve a closer look.
An Australian stockist says Braintree Hemp’s range will end after November. What its current listings establish about the clothes, timing and remaining stock.
Sovereignty ended his racing career with a Keeneland Classic win. For cannabis-aware sports fans, racing’s CBD classification deserves a separate look.
A Senate amendment would let qualifying veterans use VA diagnosis records for medical cannabis registration. It remains a proposal ahead of November 5 consideration.
Jazz reports lower quarterly Epidiolex sales but growth across nine months, while a proposed CBD capsule awaits an FDA decision targeted for April 2027.
Renaissance Fiber’s October financing announcement spotlights the processing step between US-grown hemp and fashion-ready yarn. Its new facility is not yet open.